Novavax Coronavirus Vaccine Phase 1 Data Shows Promise Unlisted Video
3 years ago
1.84K
A third US company has released research data showing its coronavirus vaccine is safe and elicits an immune response.
According to CNN, Novavax, Inc. released Phase 1 results on Tuesday.
The data shows that after two doses of the vaccine, participants developed neutralizing antibodies.
The antibodies developed were four times higher than those developed by people who had recovered from Covid-19.
The vaccine also induced a response from T-cells, a type of immune cell.
Novavax, Moderna, Pfizer, Johnson & Johnson, AstraZeneca and GlaxoSmithKline are all working on a vaccine.
Loading 1 comment...
-
0:44
Newsy
3 years agoEarly Data From Novavax COVID-19 Vaccine Shows Promise
1.9K1 -
1:23
WFTX
4 years agoPotential coronavirus vaccine shows promise
1.8K -
0:24
KTNV
3 years agoCoronavirus vaccine shows 'promising' results
146 -
1:13
Newsy
3 years agoCOVID-19 Vaccine Trials Shows Promise
1.44K1 -
0:29
Newsy
3 years agoNovavax's Potential Coronavirus Vaccine Moves To Phase 2 Trials
584 -
0:33
KTNV
3 years ago'Moderna' vaccine shows promise in trial
84 -
3:20
KGTV
3 years agoCoronavirus vaccine development
410 -
0:36
WFTX
3 years agoFinal testing begins for Coronavirus vaccine
317 -
0:30
KTNV
3 years agoCoronavirus vaccine nears final trials
541 -
1:26
WFTX
3 years agoModerna vaccine moves to phase 3
1501